Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

Under the terms of the agreement, Daiichi Sankyo will acquire world-wide rights to use ALT-B4, Alteogen's novel hyaluronidase utilizing Hybrozyme™ Technology, to develop and commercialize a ...

ALT-B4 is Alteogen's proprietary human recombinant hyaluronidase enzyme developed utilizing HybrozymeTM technology. ALT-B4 can enable the large volume subcutaneous administration of drugs that are ...

Common hormone therapies include: HER2-Positive Breast Cancer: Drugs like trastuzumab (Herceptin) and pertuzumab (Perjeta) target the HER2 protein, which promotes cancer cell growth. CDK4/6 Inhibitors ...

Some of the major updates include the approval of acalabrutinib (Calquence) for first-line treatment of mantle cell lymphoma, the FDA’s priority review of fam-trastuzumab deruxtecan-nxki (T-DXd; ...

Reported topline data results in July from the multi-center, international ASPEN-06 Phase 2 clinical trial (NCT05002127) evaluating evorpacept in combination with HERCEPTIN® (trastuzumab), CYRAMZA® ...

As per several reports online, a scientist, Beata Halassy (49), recently successfully treated her own breast cancer by ...

Dr. Dennis Slamon, director of clinical/translational research and the Revlon/UCLA Women’s Cancer Research Program at Jonsson ...

Port Hedland is encouraging more female pilots to join WA's multi-billion dollar iron ore industry. Australia takes on Pakistan in the third ODI in Perth, with the series all square at 1-1 ...

An Afghan delegation will attend the upcoming UN climate change summit in Azerbaijan, the foreign ministry spokesman told AFP on Saturday, marking a first since the Taliban government came to power.